← Browse by Condition
Medical Condition

nephrotic syndrome

Total Trials
4
Recruiting Now
4
Trial Phases
Phase 2, Phase 3, Phase 3, Phase 2

ClinicalMetric tracks all active clinical trials for nephrotic syndrome sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — nephrotic syndrome Clinical Trials

How many clinical trials are currently recruiting for nephrotic syndrome?
ClinicalMetric currently tracks 4 actively recruiting clinical trials for nephrotic syndrome, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 4. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for nephrotic syndrome?
nephrotic syndrome research spans Phase 2 (2 trials), Phase 3 (2 trials). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a nephrotic syndrome clinical trial?
Eligibility criteria for nephrotic syndrome trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 2
2
Phase 3
2
Top Sponsors
Mansoura University 1 trial
Sohag University 1 trial
Military Institute od Medicine National Research Institute 1 trial
National Institute of Allergy and Infectious Diseases (NIAID) 1 trial

Recruiting Clinical Trials

NCT07214818 Phase 2, Phase 3
Recruiting
SGLT2 Inhibitors in Adult Primary Nephrotic Syndrome
Enrollment
75 pts
Location
Egypt
Sponsor
Mansoura University
View Trial →
NCT06622915
Recruiting
Cardiac Performance Evaluation in Children With Steroid Dependent vs Steroid Resistant Nephrotic Syndrome
Enrollment
60 pts
Location
Egypt
Sponsor
Sohag University
View Trial →
NCT05716880 Phase 3
Recruiting
Ketoanalogues for Muscle Mass Loss in Nephrotic Syndrome
Enrollment
150 pts
Location
Poland
Sponsor
Military Institute od Medicine...
View Trial →
NCT03949855 Phase 2
Recruiting
Belimumab With Rituximab for Primary Membranous Nephropathy
Enrollment
58 pts
Location
United States
Sponsor
National Institute of Allergy ...
View Trial →

Related Conditions

membranous nephropathy (1)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology